speb/financial-data huggingface dataset:
ABBV cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -562000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -17000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1262000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Common Stock: 18000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2910000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -183000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -12000000.00
ABBV income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4346000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Current Assets: 29261000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Current Debt: 7522000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 7522000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 39767000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -272000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Deferred Tax: -272000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Depreciation: 186000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2050000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2050000000.00
ABBV income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1771000000.00
ABBV income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.52
ABBV income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 928000000.00
ABBV income_statement (quarterly, 2025-06-30) — EBIT: 2294000000.00
ABBV income_statement (quarterly, 2025-06-30) — EBITDA: 4344000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 30000000.00
ABBV cash_flow (quarterly, 2025-06-30) — End Cash Position: 6467000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2710000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Finished Goods: 1681000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4884000000.00
ABBV income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -23000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1538000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Goodwill: 35638000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 92669000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Gross PPE: 12934000000.00
ABBV income_statement (quarterly, 2025-06-30) — Gross Profit: 11077000000.00
ABBV income_statement (quarterly, 2025-06-30) — Interest Expense: 740000000.00
ABBV income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 740000000.00
ABBV income_statement (quarterly, 2025-06-30) — Interest Income: 62000000.00
ABBV income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 62000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Inventory: 4960000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Invested Capital: 70298000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1181000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 310000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 3963000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 62959000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 62959000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
ABBV cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3754000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Minority Interest: 45000000.00
ABBV income_statement (quarterly, 2025-06-30) — Minority Interests: -3000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -940000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -12000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Net Debt: 64014000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Income: 938000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 928000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 941000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 938000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 938000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 941000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 941000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Interest Income: -678000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -5000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 209000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -3754000000.00
ABBV income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -678000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -58000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 11000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Net PPE: 5283000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -269000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 3963000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -92852000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2554000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2554000000.00
ABBV income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 5190000000.00
ABBV income_statement (quarterly, 2025-06-30) — Normalized Income: 1450281853.28
ABBV cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 5153000000.00
ABBV income_statement (quarterly, 2025-06-30) — Operating Income: 5717000000.00
ABBV income_statement (quarterly, 2025-06-30) — Operating Revenue: 15423000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1766461114.00
ABBV balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 5197000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1538000000.00
ABBV income_statement (quarterly, 2025-06-30) — Other Income Expense: -3485000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 57031000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 3567000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 9659000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 32040000000.00
ABBV income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -2639000000.00
ABBV income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -24000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 0.00
ABBV income_statement (quarterly, 2025-06-30) — Other Special Charges: 823000000.00
ABBV income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 32245000000.00
ABBV income_statement (quarterly, 2025-06-30) — Pretax Income: 1554000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 5000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -940000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -12000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -269000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Raw Materials: 1166000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Receivables: 12637000000.00
ABBV income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4346000000.00
ABBV income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2050000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3754000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -12000000.00
ABBV income_statement (quarterly, 2025-06-30) — Research And Development: 2131000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -11503000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 7000000.00
ABBV income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3253000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Share Issued: 1837290114.00
ABBV cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 3963000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
ABBV income_statement (quarterly, 2025-06-30) — Special Income Charges: -823000000.00
ABBV cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 179000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -183000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -92852000000.00
ABBV income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -333718146.72
ABBV income_statement (quarterly, 2025-06-30) — Tax Provision: 613000000.00
ABBV income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.39
ABBV balance_sheet (quarterly, 2025-06-30) — Total Assets: 137182000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 62776000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Total Debt: 70481000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -138000000.00
ABBV income_statement (quarterly, 2025-06-30) — Total Expenses: 9706000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 137320000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 107921000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 97553000000.00
ABBV income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 4894000000.00
ABBV income_statement (quarterly, 2025-06-30) — Total Unusual Items: -846000000.00
ABBV income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -846000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 70829000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 9147000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Work In Process: 2113000000.00
ABBV balance_sheet (quarterly, 2025-06-30) — Working Capital: -10506000000.00
ABBV income_statement (quarterly, 2025-09-30) — +Operating Expense: 5888000000.00
ABBV income_statement (quarterly, 2025-09-30) — +Total Revenue: 15776000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 12769000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -7746000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 22291000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 1871000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 1871000000.00
ABBV income_statement (quarterly, 2025-09-30) — Basic Average Shares: 1767349878.00
ABBV income_statement (quarterly, 2025-09-30) — Basic EPS: 0.11
ABBV cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 6467000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -381000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Capital Stock: 18000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5629000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5671000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2911000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -4590000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3264000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 7024000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1730000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Inventory: 2000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -411000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Payable: 1730000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1730000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 88000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Receivables: -156000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1253000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -156000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Changes In Cash: -830000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Common Stock: 18000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -2911000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -2642000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -4000000.00
ABBV income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5304000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Current Assets: 28539000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Current Debt: 5772000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5772000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 39391000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 193000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Deferred Tax: 193000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Depreciation: 192000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2063000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2063000000.00
ABBV income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 1772000000.00
ABBV income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.10
ABBV income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 176000000.00
ABBV income_statement (quarterly, 2025-09-30) — EBIT: 1453000000.00
ABBV income_statement (quarterly, 2025-09-30) — EBITDA: 3516000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -8000000.00
ABBV cash_flow (quarterly, 2025-09-30) — End Cash Position: 5629000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -4590000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Finished Goods: 1579000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 6643000000.00
ABBV income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -20000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1574000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Goodwill: 35626000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 89941000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Gross PPE: 13229000000.00
ABBV income_statement (quarterly, 2025-09-30) — Gross Profit: 10472000000.00
ABBV income_statement (quarterly, 2025-09-30) — Interest Expense: 739000000.00
ABBV income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 739000000.00
ABBV income_statement (quarterly, 2025-09-30) — Interest Income: 72000000.00
ABBV income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 72000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 739000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Inventory: 4938000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Invested Capital: 66101000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3264000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 291000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 241000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 62971000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 62971000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
ABBV cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -9000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Minority Interest: 43000000.00
ABBV income_statement (quarterly, 2025-09-30) — Minority Interests: -2000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -2802000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -4000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Net Debt: 63114000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Income: 186000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 176000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 188000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 186000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 186000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 188000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 188000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Interest Income: -667000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -4000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1775000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -9000000.00
ABBV income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -667000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 37000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -77000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Net PPE: 5483000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -381000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1766000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -92583000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 2480000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2480000000.00
ABBV income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 6216000000.00
ABBV income_statement (quarterly, 2025-09-30) — Normalized Income: 2319000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 7024000000.00
ABBV income_statement (quarterly, 2025-09-30) — Operating Income: 4584000000.00
ABBV income_statement (quarterly, 2025-09-30) — Operating Revenue: 15776000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1767349878.00
ABBV balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5161000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1574000000.00
ABBV income_statement (quarterly, 2025-09-30) — Other Income Expense: -3203000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 54315000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 2590000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 9644000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 31655000000.00
ABBV income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -503000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 42000000.00
ABBV income_statement (quarterly, 2025-09-30) — Other Special Charges: 2680000000.00
ABBV income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 33619000000.00
ABBV income_statement (quarterly, 2025-09-30) — Pretax Income: 714000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 63000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -319000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -2802000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -7000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -381000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Raw Materials: 1082000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Receivables: 12769000000.00
ABBV income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5304000000.00
ABBV income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2063000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -2016000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -4000000.00
ABBV income_statement (quarterly, 2025-09-30) — Research And Development: 2319000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -14234000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3000000.00
ABBV income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3569000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Share Issued: 1838138571.00
ABBV cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 241000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -2007000000.00
ABBV income_statement (quarterly, 2025-09-30) — Special Income Charges: -2680000000.00
ABBV cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 209000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -2642000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -92583000000.00
ABBV income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -567000000.00
ABBV income_statement (quarterly, 2025-09-30) — Tax Provision: 526000000.00
ABBV income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
ABBV balance_sheet (quarterly, 2025-09-30) — Total Assets: 133898000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 60329000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Total Debt: 68743000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -2599000000.00
ABBV income_statement (quarterly, 2025-09-30) — Total Expenses: 11192000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 136497000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 105359000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 97106000000.00
ABBV income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 1904000000.00
ABBV income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2700000000.00
ABBV income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2700000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 70788693.00
ABBV balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 9143000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Work In Process: 2277000000.00
ABBV balance_sheet (quarterly, 2025-09-30) — Working Capital: -10852000000.00
ABBV income_statement (annual, 2025-12-31) — +Operating Expense: 22865000000.00
ABBV income_statement (quarterly, 2025-12-31) — +Operating Expense: 6257000000.00
ABBV income_statement (annual, 2025-12-31) — +Total Revenue: 61160000000.00
ABBV income_statement (quarterly, 2025-12-31) — +Total Revenue: 16618000000.00
ABBV balance_sheet (annual, 2025-12-31) — Accounts Payable: 3592000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3592000000.00
ABBV balance_sheet (annual, 2025-12-31) — Accounts Receivable: 12589000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 12589000000.00
ABBV balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7902000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7902000000.00
ABBV balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 22495000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 22495000000.00
ABBV cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 7377000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1784000000.00
ABBV cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 7377000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1784000000.00
ABBV cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 847000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
ABBV income_statement (annual, 2025-12-31) — Basic Average Shares: 1767876035.00
ABBV income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1767876035.00
ABBV income_statement (annual, 2025-12-31) — Basic EPS: 2.39
ABBV income_statement (quarterly, 2025-12-31) — Basic EPS: 1.03
ABBV cash_flow (annual, 2025-12-31) — Beginning Cash Position: 5524000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5629000000.00
ABBV balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 3057000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 3057000000.00
ABBV cash_flow (annual, 2025-12-31) — Capital Expenditure: -1214000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -329000000.00
ABBV balance_sheet (annual, 2025-12-31) — Capital Stock: 18000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Capital Stock: 18000000.00
ABBV balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5229000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5229000000.00
ABBV balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5257000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5257000000.00
ABBV cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -11657000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2911000000.00
ABBV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -12724000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4166000000.00
ABBV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -6643000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1463000000.00
ABBV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 19030000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5218000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Account Payable: 951000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -598000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Inventory: -234000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Inventory: -25000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -762000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 646000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Payable: 951000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Payable: -598000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 951000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -598000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -827000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -658000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Receivables: -1490000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Receivables: 162000000.00
ABBV cash_flow (annual, 2025-12-31) — Change In Working Capital: -2362000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -473000000.00
ABBV cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1490000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 162000000.00
ABBV cash_flow (annual, 2025-12-31) — Changes In Cash: -337000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Changes In Cash: -411000000.00
ABBV balance_sheet (annual, 2025-12-31) — Common Stock: 18000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Common Stock: 18000000.00
ABBV cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -11657000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -2911000000.00
ABBV balance_sheet (annual, 2025-12-31) — Common Stock Equity: -3270000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -3270000000.00
ABBV cash_flow (annual, 2025-12-31) — Common Stock Payments: -980000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -3000000.00
ABBV balance_sheet (annual, 2025-12-31) — Construction In Progress: 1401000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1401000000.00
ABBV income_statement (annual, 2025-12-31) — Cost Of Revenue: 18204000000.00
ABBV income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4552000000.00
ABBV balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 28043000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 28043000000.00
ABBV balance_sheet (annual, 2025-12-31) — Current Assets: 29062000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Current Assets: 29062000000.00
ABBV balance_sheet (annual, 2025-12-31) — Current Debt: 8555000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Current Debt: 8555000000.00
ABBV balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 8555000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 8555000000.00
ABBV balance_sheet (annual, 2025-12-31) — Current Liabilities: 43289000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 43289000000.00
ABBV cash_flow (annual, 2025-12-31) — Deferred Income Tax: -492000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -385000000.00
ABBV cash_flow (annual, 2025-12-31) — Deferred Tax: -492000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Deferred Tax: -385000000.00
ABBV cash_flow (annual, 2025-12-31) — Depreciation: 762000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Depreciation: 203000000.00
ABBV cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 8139000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1987000000.00
ABBV cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 8139000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1987000000.00
ABBV income_statement (annual, 2025-12-31) — Diluted Average Shares: 1773000000.00
ABBV income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1774000000.00
ABBV income_statement (annual, 2025-12-31) — Diluted EPS: 2.36
ABBV income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.02
ABBV income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 4186000000.00
ABBV income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1806000000.00
ABBV balance_sheet (annual, 2025-12-31) — Dividends Payable: 3099000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 3099000000.00
ABBV income_statement (annual, 2025-12-31) — EBIT: 9490000000.00
ABBV income_statement (quarterly, 2025-12-31) — EBIT: 3382000000.00
ABBV income_statement (annual, 2025-12-31) — EBITDA: 17629000000.00
ABBV income_statement (quarterly, 2025-12-31) — EBITDA: 5369000000.00
ABBV cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 42000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 11000000.00
ABBV balance_sheet (annual, 2025-12-31) — Employee Benefits: 1410000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1410000000.00
ABBV cash_flow (annual, 2025-12-31) — End Cash Position: 5229000000.00
ABBV cash_flow (quarterly, 2025-12-31) — End Cash Position: 5229000000.00
ABBV cash_flow (annual, 2025-12-31) — Financing Cash Flow: -12724000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4166000000.00
ABBV balance_sheet (annual, 2025-12-31) — Finished Goods: 1580000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1580000000.00
ABBV cash_flow (annual, 2025-12-31) — Free Cash Flow: 17816000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4889000000.00
ABBV income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -58000000.00
ABBV income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -11000000.00
ABBV balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1144000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1144000000.00
ABBV balance_sheet (annual, 2025-12-31) — Goodwill: 35640000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Goodwill: 35640000000.00
ABBV balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 88281000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 88281000000.00
ABBV balance_sheet (annual, 2025-12-31) — Gross PPE: 13530000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Gross PPE: 13530000000.00
ABBV income_statement (annual, 2025-12-31) — Gross Profit: 42956000000.00
ABBV income_statement (quarterly, 2025-12-31) — Gross Profit: 12066000000.00
ABBV cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3626000000.00
ABBV income_statement (annual, 2025-12-31) — Interest Expense: 2893000000.00
ABBV income_statement (quarterly, 2025-12-31) — Interest Expense: 714000000.00
ABBV income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2893000000.00
ABBV income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 714000000.00
ABBV income_statement (annual, 2025-12-31) — Interest Income: 266000000.00
ABBV income_statement (quarterly, 2025-12-31) — Interest Income: 59000000.00
ABBV income_statement (annual, 2025-12-31) — Interest Income Non Operating: 266000000.00
ABBV income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 59000000.00
ABBV cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3002000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 823000000.00
ABBV balance_sheet (annual, 2025-12-31) — Inventory: 4951000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Inventory: 4951000000.00
ABBV balance_sheet (annual, 2025-12-31) — Invested Capital: 64226000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Invested Capital: 64226000000.00
ABBV cash_flow (annual, 2025-12-31) — Investing Cash Flow: -6643000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1463000000.00
ABBV balance_sheet (annual, 2025-12-31) — Investments And Advances: 268000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 268000000.00
ABBV cash_flow (annual, 2025-12-31) — Issuance Of Debt: 9291000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -500000000.00
ABBV balance_sheet (annual, 2025-12-31) — Land And Improvements: 287000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 287000000.00
ABBV balance_sheet (annual, 2025-12-31) — Long Term Debt: 58941000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 58941000000.00
ABBV balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 58941000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 58941000000.00
ABBV cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3994000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
ABBV cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -6797000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -8000000.00
ABBV balance_sheet (annual, 2025-12-31) — Minority Interest: 42000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Minority Interest: 42000000.00
ABBV income_statement (annual, 2025-12-31) — Minority Interests: -7000000.00
ABBV income_statement (quarterly, 2025-12-31) — Minority Interests: 1000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -5441000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -1161000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -980000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -3000000.00
ABBV balance_sheet (annual, 2025-12-31) — Net Debt: 62267000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Net Debt: 62267000000.00
ABBV income_statement (annual, 2025-12-31) — Net Income: 4226000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Income: 1816000000.00
ABBV income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 4186000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1806000000.00
ABBV income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4233000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1815000000.00
ABBV income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4226000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1816000000.00
ABBV income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4226000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1816000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 4233000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1815000000.00
ABBV income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 4233000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1815000000.00
ABBV income_statement (annual, 2025-12-31) — Net Interest Income: -2627000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Interest Income: -655000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 41000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 28000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -304000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1299000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -2803000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -8000000.00
ABBV income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2627000000.00
ABBV income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -655000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 45000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -29000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1000000.00
ABBV balance_sheet (annual, 2025-12-31) — Net PPE: 5628000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Net PPE: 5628000000.00
ABBV cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1214000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -329000000.00
ABBV cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 2499000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -1291000000.00
ABBV balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -91551000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -91551000000.00
ABBV balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 2389000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2389000000.00
ABBV balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2389000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2389000000.00
ABBV balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1410000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1410000000.00
ABBV income_statement (annual, 2025-12-31) — Normalized EBITDA: 22703000000.00
ABBV income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 6645000000.00
ABBV income_statement (annual, 2025-12-31) — Normalized Income: 7481758981.36
ABBV income_statement (quarterly, 2025-12-31) — Normalized Income: 2684043478.26
ABBV cash_flow (annual, 2025-12-31) — Operating Cash Flow: 19030000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5218000000.00
ABBV income_statement (annual, 2025-12-31) — Operating Income: 20091000000.00
ABBV income_statement (quarterly, 2025-12-31) — Operating Income: 5809000000.00
ABBV income_statement (annual, 2025-12-31) — Operating Revenue: 61160000000.00
ABBV income_statement (quarterly, 2025-12-31) — Operating Revenue: 16618000000.00
ABBV balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1767876035.00
ABBV balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1767876035.00
ABBV balance_sheet (annual, 2025-12-31) — Other Current Assets: 6265000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6265000000.00
ABBV balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1144000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1144000000.00
ABBV income_statement (annual, 2025-12-31) — Other Income Expense: -10867000000.00
ABBV income_statement (quarterly, 2025-12-31) — Other Income Expense: -2486000000.00
ABBV balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 52641000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 52641000000.00
ABBV cash_flow (annual, 2025-12-31) — Other Non Cash Items: 8643000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1981000000.00
ABBV balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 10721000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 10721000000.00
ABBV balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 30795000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 30795000000.00
ABBV income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -5793000000.00
ABBV income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1210000000.00
ABBV income_statement (annual, 2025-12-31) — Other Operating Expenses: -241000000.00
ABBV income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -217000000.00
ABBV balance_sheet (annual, 2025-12-31) — Other Properties: 8785000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Other Properties: 8785000000.00
ABBV balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 28000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 28000000.00
ABBV income_statement (annual, 2025-12-31) — Other Special Charges: 5016000000.00
ABBV income_statement (quarterly, 2025-12-31) — Other Special Charges: 1265000000.00
ABBV income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 40000000.00
ABBV income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV balance_sheet (annual, 2025-12-31) — Payables: 6691000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Payables: 6691000000.00
ABBV balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 34734000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 34734000000.00
ABBV income_statement (annual, 2025-12-31) — Pretax Income: 6597000000.00
ABBV income_statement (quarterly, 2025-12-31) — Pretax Income: 2668000000.00
ABBV cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 172000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 48000000.00
ABBV balance_sheet (annual, 2025-12-31) — Properties: 0.00
ABBV balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ABBV cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -933000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 136000000.00
ABBV cash_flow (annual, 2025-12-31) — Purchase Of Business: -5441000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -1161000000.00
ABBV cash_flow (annual, 2025-12-31) — Purchase Of Investment: -35000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -6000000.00
ABBV cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1214000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -329000000.00
ABBV balance_sheet (annual, 2025-12-31) — Raw Materials: 1084000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1084000000.00
ABBV balance_sheet (annual, 2025-12-31) — Receivables: 12589000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Receivables: 12589000000.00
ABBV income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 18204000000.00
ABBV income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4552000000.00
ABBV income_statement (annual, 2025-12-31) — Reconciled Depreciation: 8139000000.00
ABBV income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1987000000.00
ABBV cash_flow (annual, 2025-12-31) — Repayment Of Debt: -9595000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -799000000.00
ABBV cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -980000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -3000000.00
ABBV income_statement (annual, 2025-12-31) — Research And Development: 9096000000.00
ABBV income_statement (quarterly, 2025-12-31) — Research And Development: 2579000000.00
ABBV balance_sheet (annual, 2025-12-31) — Retained Earnings: -15493000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -15493000000.00
ABBV cash_flow (annual, 2025-12-31) — Sale Of Investment: 76000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 34000000.00
ABBV income_statement (annual, 2025-12-31) — Selling General And Administration: 14010000000.00
ABBV income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3895000000.00
ABBV balance_sheet (annual, 2025-12-31) — Share Issued: 1838678628.00
ABBV balance_sheet (quarterly, 2025-12-31) — Share Issued: 1838678628.00
ABBV cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 5297000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -500000000.00
ABBV cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -2798000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -791000000.00
ABBV income_statement (annual, 2025-12-31) — Special Income Charges: -5016000000.00
ABBV income_statement (quarterly, 2025-12-31) — Special Income Charges: -1265000000.00
ABBV cash_flow (annual, 2025-12-31) — Stock Based Compensation: 955000000.00
ABBV cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 157000000.00
ABBV balance_sheet (annual, 2025-12-31) — Stockholders Equity: -3270000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -3270000000.00
ABBV balance_sheet (annual, 2025-12-31) — Tangible Book Value: -91551000000.00
ABBV balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -91551000000.00
ABBV income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1818241018.64
ABBV income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -407956521.74
ABBV income_statement (annual, 2025-12-31) — Tax Provision: 2364000000.00
ABBV income_statement (quarterly, 2025-12-31) — Tax Provision: 853000000.00
ABBV income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.36